LIFE - aTyr Pharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 7/8/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
40.06M26.19M16.23M13.62M18.10M
Enterprise Value 3
-86.02k-2.72M-8.08M-13.03M-7.19M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
2.2622.2643.8292.74N/A
Price/Book (mrq)
0.951.250.610.450.61
Enterprise Value/Revenue 3
-0.01-0.34-56.11-70.80-76.49
Enterprise Value/EBITDA 6
0.01-1.231.442.531.36

Trading Information

Stock Price History

Beta (5Y Monthly) 2.33
52-Week Change 3-18.63%
S&P500 52-Week Change 35.66%
52 Week High 37.6200
52 Week Low 32.1300
50-Day Moving Average 34.0330
200-Day Moving Average 33.9944

Share Statistics

Avg Vol (3 month) 3148.82k
Avg Vol (10 day) 347.08k
Shares Outstanding 59.36M
Float 7.02M
% Held by Insiders 15.60%
% Held by Institutions 131.33%
Shares Short (Jun 14, 2020) 438.37k
Short Ratio (Jun 14, 2020) 40.45
Short % of Float (Jun 14, 2020) 40.45%
Short % of Shares Outstanding (Jun 14, 2020) 40.41%
Shares Short (prior month May 14, 2020) 430.12k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:14
Last Split Date 3Jun 30, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin -185.14%
Operating Margin (ttm)-179.59%

Management Effectiveness

Return on Assets (ttm)-18.26%
Return on Equity (ttm)-44.43%

Income Statement

Revenue (ttm)8.49M
Revenue Per Share (ttm)1.90
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-13.63M
EBITDA -14.62M
Net Income Avi to Common (ttm)-15.71M
Diluted EPS (ttm)-3.5200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)49.83M
Total Cash Per Share (mrq)5.33
Total Debt (mrq)9.68M
Total Debt/Equity (mrq)23.07
Current Ratio (mrq)4.82
Book Value Per Share (mrq)4.50

Cash Flow Statement

Operating Cash Flow (ttm)-11.93M
Levered Free Cash Flow (ttm)-4.83M